Skip Header

Contribute Send feedback
Read comments (?) or add your own

P17302 (CXA1_HUMAN) Reviewed, UniProtKB/Swiss-Prot

Last modified January 25, 2012. Version 153. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (5) | Third-party data text xml rdf/xml gff fasta
to top of pageNames·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order

Names and origin

Protein namesRecommended name:
Gap junction alpha-1 protein
Alternative name(s):
Connexin-43
Short name=Cx43
Gap junction 43 kDa heart protein
Gene names
Name:GJA1
Synonyms:GJAL
OrganismHomo sapiens (Human)
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length382 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is further processed into a mature form.
Protein existenceEvidence at protein level

General annotation (Comments)

Function

One gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell. May play a critical role in the physiology of hearing by participating in the recycling of potassium to the cochlear endolymph.

Subunit structure

A connexon is composed of a hexamer of connexins. Interacts (via C-terminus) with TJP1. Interacts (via C-terminus) with SRC (via SH3 domain) By similarity. Interacts with SGSM3. Interacts with KIAA1432/CIP150. Interacts with CNST and CSNK1D. Ref.16 Ref.17

Subcellular location

Cell membrane; Multi-pass membrane protein. Cell junctiongap junction.

Tissue specificity

Expressed in the heart and fetal cochlea. Ref.15

Post-translational modification

Phosphorylated at Ser-368 by PRKCG; phosphorylation induces disassembly of gap junction plaques and inhibition of gap junction activity By similarity. Phosphorylation at Ser-325, Ser-328 and Ser-330 by CK1 modulates gap junction assembly. Ref.10 Ref.16 Ref.19

Involvement in disease

Defects in GJA1 are the cause of autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200]; also known as oculodentoosseous dysplasia. ODDD is a highly penetrant syndrome presenting with craniofacial (ocular, nasal, dental) and limb dysmorphisms, spastic paraplegia, and neurodegeneration. Craniofacial anomalies tipically include a thin nose with hypoplastic alae nasi, small anteverted nares, prominent columnella, and microcephaly. Brittle nails and hair abnormalities of hypotrichosis and slow growth are present. Ocular defects include microphthalmia, microcornea, cataracts, glaucoma, and optic atrophy. Syndactyly type 3 and conductive deafness can occur in some cases. Cardiac abnormalities are observed in rare instances. Ref.18 Ref.20 Ref.23 Ref.25 Ref.26 Ref.27 Ref.28 Ref.31 Ref.32 Ref.33 Ref.34 Ref.35 Ref.36

Defects in GJA1 are the cause of autosomal recessive oculodentodigital dysplasia (ODDD autosomal recessive) [MIM:257850].

Defects in GJA1 may be the cause of syndactyly type 3 (SDTY3) [MIM:186100]. Syndactyly is an autosomal dominant trait and is the most common congenital anomaly of the hand or foot. It is marked by persistence of the webbing between adjacent digits, so they are more or less completely attached. In this type there is usually complete and bilateral syndactyly between the fourth and fifth fingers. Usually it is soft tissue syndactyly but occasionally the distal phalanges are fused. The fifth finger is short with absent or rudimentary middle phalanx. The feet are not affected. Ref.25

Defects in GJA1 are a cause of hypoplastic left heart syndrome (HLHS) [MIM:241550]. HLHS refers to the abnormal development of the left-sided cardiac structures, resulting in obstruction to blood flow from the left ventricular outflow tract. In addition, the syndrome includes underdevelopment of the left ventricle, aorta, and aortic arch, as well as mitral atresia or stenosis. Ref.22

Defects in GJA1 are a cause of Hallermann-Streiff syndrome (HSS) [MIM:234100]. HSS is a disorder characterized by a typical skull shape (brachycephaly with frontal bossing), hypotrichosis, microphthalmia, cataracts, beaked nose, micrognathia, skin atrophy, dental anomalies and proportionate short stature. Mental retardation is present in a minority of cases. Ref.24

Defects in GJA1 are a cause of atrioventricular septal defect type 3 (AVSD3) [MIM:600309]. A congenital heart malformation characterized by a common atrioventricular junction coexisting with deficient atrioventricular septation. The complete form involves underdevelopment of the lower part of the atrial septum and the upper part of the ventricular septum. A less severe form, known as ostium primum atrial septal defect, has a deficiency of the atrial septum. Ref.22

Sequence similarities

Belongs to the connexin family. Alpha-type (group II) subfamily.

Caution

Ref.21 reported a mutation Pro-364 linked to congenital heart diseases. Ref.12 later shown that it is an artifact.

Ref.15 reported 2 mutations (Phe-11 and Ala-24) linked to non-syndromic autosomal recessive deafness (DFNBG). These mutations have subsequently been shown (Ref.20) to involve the pseudogene of connexin-43 located on chromosome 5.

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Initiator methionine11Removed By similarity
Chain2 – 382381Gap junction alpha-1 protein
PRO_0000057801

Regions

Topological domain2 – 1312Cytoplasmic Potential
Transmembrane14 – 3623Helical; Potential
Topological domain37 – 7640Extracellular Potential
Transmembrane77 – 9923Helical; Potential
Topological domain100 – 15455Cytoplasmic Potential
Transmembrane155 – 17723Helical; Potential
Topological domain178 – 20831Extracellular Potential
Transmembrane209 – 23123Helical; Potential
Topological domain232 – 382151Cytoplasmic Potential

Amino acid modifications

Modified residue2471Phosphotyrosine Ref.19
Modified residue2621Phosphoserine Ref.10
Modified residue3061Phosphoserine By similarity
Modified residue3131Phosphotyrosine Ref.19
Modified residue3141Phosphoserine By similarity
Modified residue3251Phosphoserine; by CK1 Ref.16
Modified residue3261Phosphothreonine By similarity
Modified residue3281Phosphoserine; by CK1 Ref.16
Modified residue3301Phosphoserine; by CK1 Ref.16
Modified residue3651Phosphoserine By similarity
Modified residue3681Phosphoserine; by PKC/PRKCG By similarity
Modified residue3691Phosphoserine By similarity
Modified residue3731Phosphoserine By similarity
Disulfide bond54 ↔ 192 Ref.9
Disulfide bond187 ↔ 198 Ref.9

Natural variations

Natural variant21G → V in ODDD. Ref.35
VAR_058990
Natural variant71L → V in ODDD. Ref.36
VAR_058991
Natural variant111L → P in ODDD. Ref.33
VAR_058992
Natural variant171Y → S in ODDD. Ref.20
VAR_015747
Natural variant181S → P in ODDD. Ref.20
VAR_015748
Natural variant211G → R in ODDD; involvement of only the fourth and fifth fingers; SDTY3. Ref.20
VAR_015749
Natural variant221G → E in ODDD; involvement of only the fourth and fifth fingers; SDTY3. Ref.20
VAR_015750
Natural variant231K → T in ODDD. Ref.20
VAR_015751
Natural variant271S → P in ODDD. Ref.25
VAR_038356
Natural variant311I → M in ODDD. Ref.25
VAR_038357
Natural variant401A → V in ODDD. Ref.20 Ref.25 Ref.31 Ref.36
VAR_015752
Natural variant411V → L in ectodermal and oculodentodigital dysplasia; with skin hyperkeratosis; associated with GJB2 variant His-127. Ref.30
VAR_058993
Natural variant491Q → K in ODDD. Ref.20
VAR_015753
Natural variant491Q → P in ODDD. Ref.36
VAR_058994
Natural variant491Q → QQ in ODDD. Ref.36
VAR_058995
Natural variant521F → FF in ODDD. Ref.20
VAR_015754
Natural variant591P → H in ODDD. Ref.28
VAR_058996
Natural variant691S → Y in ODDD. Ref.25
VAR_038358
Natural variant761R → H in HSS; overlapping features with oculodentodigital dysplasia. Ref.24
VAR_058997
Natural variant761R → S in ODDD. Ref.20
VAR_015755
Natural variant901L → V in ODDD. Ref.20
VAR_015756
Natural variant951H → R in ODDD. Ref.27
VAR_058998
Natural variant961V → A in ODDD. Ref.36
VAR_058999
Natural variant961V → E in ODDD. Ref.32
VAR_059000
Natural variant961V → M in ODDD. Ref.23
Corresponds to variant rs28931601 [ dbSNP | Ensembl ].
VAR_059001
Natural variant981Y → C in ODDD. Ref.20
VAR_015757
Natural variant1021K → N in ODDD. Ref.20
VAR_015758
Natural variant1061L → P in ODDD. Ref.36
VAR_059002
Natural variant1101E → D in ODDD. Ref.31
VAR_059003
Natural variant1131L → P in ODDD. Ref.25 Ref.32
VAR_038359
Natural variant1241D → E.
Corresponds to variant rs2228966 [ dbSNP | Ensembl ].
VAR_014094
Natural variant1301I → T in ODDD. Ref.20
VAR_015759
Natural variant1341K → E in ODDD. Ref.20
VAR_015760
Natural variant1341K → N in ODDD. Ref.25
VAR_038360
Natural variant1381G → R in ODDD. Ref.20
VAR_015761
Natural variant1431G → S in SDTY3. Ref.25
Corresponds to variant rs28931600 [ dbSNP | Ensembl ].
VAR_038361
Natural variant1471M → T in ODDD. Ref.31
VAR_059004
Natural variant1481R → Q. Ref.25
Corresponds to variant rs2228960 [ dbSNP | Ensembl ].
VAR_014095
Natural variant1541T → A in ODDD. Ref.34 Ref.36
VAR_059005
Natural variant1541T → N in ODDD. Ref.32
VAR_059006
Natural variant1681A → T.
Corresponds to variant rs2228961 [ dbSNP | Ensembl ].
VAR_014096
Natural variant1691Missing in ODDD.
VAR_059007
Natural variant1851Y → H.
Corresponds to variant rs2228962 [ dbSNP | Ensembl ].
VAR_014097
Natural variant1941H → P in ODDD; atypical form of ODDD characterized by the predominance of the ocular involvement and by the absence of hand and/or foot syndactyly and absence of any neurologic signs. Ref.26
VAR_059008
Natural variant2011S → F in ODDD. Ref.36
VAR_059009
Natural variant2021R → C.
Corresponds to variant rs2228964 [ dbSNP | Ensembl ].
VAR_014098
Natural variant2021R → H in ODDD. Ref.20 Ref.25 Ref.36
VAR_015762
Natural variant2041T → M.
Corresponds to variant rs2228965 [ dbSNP | Ensembl ].
VAR_014099
Natural variant2161V → L in ODDD. Ref.20
VAR_015763
Natural variant2201S → Y in ODDD. Ref.32
VAR_059010
Natural variant2391R → W in congenital heart malformations. Ref.29
Corresponds to variant rs2227887 [ dbSNP | Ensembl ].
VAR_014100
Natural variant2511S → T in congenital heart malformations. Ref.29
VAR_059011
Natural variant2531A → P in congenital heart malformations. Ref.29
VAR_059012
Natural variant2531A → V. Ref.20
Corresponds to variant rs17653265 [ dbSNP | Ensembl ].
VAR_015764
Natural variant2831P → L in congenital heart malformations. Ref.29
Corresponds to variant rs2228974 [ dbSNP | Ensembl ].
VAR_014101
Natural variant2901T → N in congenital heart malformations. Ref.29
Corresponds to variant rs2227881 [ dbSNP | Ensembl ].
VAR_014102
Natural variant3261T → A. Ref.21
VAR_059013
Natural variant3521E → G in heart malformations. Ref.21
VAR_059014
Natural variant3621R → Q in HLHS and AVSD3; associated with Gln-376 in one individual with atrioventricular septal defect;; abolishes phosphorylation by PKA and PKC. Ref.22
Corresponds to variant rs2227885 [ dbSNP | Ensembl ].
VAR_032924
Natural variant3641S → P in heart malformations; shows abnormalities in the regulation of cell-cell communication as compared with cells expressing normal GJA1. Ref.21
VAR_059015
Natural variant3651S → N in heart malformations. Ref.21
VAR_059016
Natural variant3731S → G. Ref.21
VAR_059017
Natural variant3761R → Q in HLHS and AVSD3; associated with Gln-362 in one individual with atrioventricular septal defect; abolishes phosphorylation by PKA and PKC. Ref.22
VAR_032925

Sequences

Sequence LengthMass (Da)Tools
P17302 [UniParc].

Last modified January 23, 2007. Version 2.
Checksum: 7DDDAD8040284176

FASTA38243,008
        10         20         30         40         50         60 
MGDWSALGKL LDKVQAYSTA GGKVWLSVLF IFRILLLGTA VESAWGDEQS AFRCNTQQPG 

        70         80         90        100        110        120 
CENVCYDKSF PISHVRFWVL QIIFVSVPTL LYLAHVFYVM RKEEKLNKKE EELKVAQTDG 

       130        140        150        160        170        180 
VNVDMHLKQI EIKKFKYGIE EHGKVKMRGG LLRTYIISIL FKSIFEVAFL LIQWYIYGFS 

       190        200        210        220        230        240 
LSAVYTCKRD PCPHQVDCFL SRPTEKTIFI IFMLVVSLVS LALNIIELFY VFFKGVKDRV 

       250        260        270        280        290        300 
KGKSDPYHAT SGALSPAKDC GSQKYAYFNG CSSPTAPLSP MSPPGYKLVT GDRNNSSCRN 

       310        320        330        340        350        360 
YNKQASEQNW ANYSAEQNRM GQAGSTISNS HAQPFDFPDD NQNSKKLAAG HELQPLAIVD 

       370        380 
QRPSSRASSR ASSRPRPDDL EI 

« Hide

References

« Hide 'large scale' references
[1]"Molecular characterization and functional expression of the human cardiac gap junction channel."
Fishman G.I., Spray D.C., Leinwand L.A.
J. Cell Biol. 111:589-598(1990) [PubMed: 1696265] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA].
Tissue: Heart muscle.
[2]"The human connexin gene family of gap junction proteins: distinct chromosomal locations but similar structures."
Fishman G.I., Eddy R.L., Shows T.B., Rosenthal L., Leinwand L.A.
Genomics 10:250-256(1991) [PubMed: 1646158] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA].
[3]"Sporadic cases of dilated cardiomyopathies associated with atrioventricular conduction defects are not linked to mutation within the connexins 40 and 43 genes."
Haefliger J.-A., Goy J.J., Waeber G.
Eur. Heart J. 20:1843-1843(1999) [PubMed: 10581143] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA].
[4]"Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201)."
Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S., Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W., Korn B., Zuo D., Hu Y., LaBaer J.
Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
[5]"Complete sequencing and characterization of 21,243 full-length human cDNAs."
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. expand/collapse author list , Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.
Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
Tissue: Cerebellum.
[6]"The DNA sequence and analysis of human chromosome 6."
Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L., Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D., Andrews T.D. expand/collapse author list , Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V., Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J., Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J., French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M., Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.
Nature 425:805-811(2003) [PubMed: 14574404] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[7]Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. expand/collapse author list , Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W., Venter J.C.
Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[8]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
Tissue: Brain.
[9]"Intercellular calcium signaling via gap junction in connexin-43-transfected cells."
Toyofuku T., Yabuki M., Otsu K., Kuzuya T., Hori M., Tada M.
J. Biol. Chem. 273:1519-1528(1998) [PubMed: 9430691] [Abstract]
Cited for: DISULFIDE BONDS.
[10]"Phosphorylation of serine 262 in the gap junction protein connexin-43 regulates DNA synthesis in cell-cell contact forming cardiomyocytes."
Doble B.W., Dang X., Ping P., Fandrich R.R., Nickel B.E., Jin Y., Cattini P.A., Kardami E.
J. Cell Sci. 117:507-514(2004) [PubMed: 14702389] [Abstract]
Cited for: PHOSPHORYLATION AT SER-262.
[11]"Connexin expression and turnover: implications for cardiac excitability."
Saffitz J.E., Laing J.G., Yamada K.A.
Circ. Res. 86:723-728(2000) [PubMed: 10764404] [Abstract]
Cited for: REVIEW.
[12]"Failure to detect connexin43 mutations in 38 cases of sporadic and familial heterotaxy."
Gebbia M., Towbin J.A., Casey B.
Circulation 94:1909-1912(1996) [PubMed: 8873667] [Abstract]
Cited for: SHOWS THAT HEART LATERALIZATION DEFECT ARE NOT DUE TO GJA1.
[13]"Absence of mutations in the regulatory domain of the gap junction protein connexin 43 in patients with visceroatrial heterotaxy."
Penman Splitt M., Tsai M.Y., Burn J., Goodship J.A.
Heart 77:369-370(1997) [PubMed: 9155619] [Abstract]
Cited for: SHOWS THAT HEART LATERALIZATION DEFECT ARE NOT DUE TO GJA1.
[14]"Connexin43 gene mutations and heterotaxy."
Toth T., Hajdu J., Marton T., Nagy B., Papp Z.
Circulation 97:117-118(1998) [PubMed: 9443444] [Abstract]
Cited for: SHOWS THAT HEART LATERALIZATION DEFECT ARE NOT DUE TO GJA1.
[15]"Mutations in GJA1 (connexin 43) are associated with non-syndromic autosomal recessive deafness."
Liu X.Z., Xia X.J., Adams J., Chen Z.Y., Welch K.O., Tekin M., Ouyang X.M., Kristiansen A., Pandya A., Balkany T., Arnos K.S., Nance W.E.
Hum. Mol. Genet. 10:2945-2951(2001) [PubMed: 11741837] [Abstract]
Cited for: ASSOCIATION WITH NON-SYNDROMIC AUTOSOMAL RECESSIVE DEAFNESS, TISSUE SPECIFICITY.
[16]"Casein kinase 1 regulates connexin-43 gap junction assembly."
Cooper C.D., Lampe P.D.
J. Biol. Chem. 277:44962-44968(2002) [PubMed: 12270943] [Abstract]
Cited for: PHOSPHORYLATION AT SER-325; SER-328 AND SER-330 BY CSNK1D/CK1, INTERACTION WITH CSNK1D.
[17]"Molecular cloning and functional analysis of a novel Cx43 partner protein CIP150."
Akiyama M., Ishida N., Ogawa T., Yogo K., Takeya T.
Biochem. Biophys. Res. Commun. 335:1264-1271(2005) [PubMed: 16112082] [Abstract]
Cited for: INTERACTION WITH KIAA1432.
[18]"A nonsense mutation in the first transmembrane domain of connexin 43 underlies autosomal recessive oculodentodigital syndrome."
Richardson R.J., Joss S., Tomkin S., Ahmed M., Sheridan E., Dixon M.J.
J. Med. Genet. 43:E37-E37(2006) [PubMed: 16816024] [Abstract]
Cited for: INVOLVEMENT IN ODDD AUTOSOMAL RECESSIVE.
[19]"Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer."
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J., Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L., Mitchell J., Wetzel R., Macneill J., Ren J.M. expand/collapse author list , Yuan J., Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X., Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.
Cell 131:1190-1203(2007) [PubMed: 18083107] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-247 AND TYR-313, MASS SPECTROMETRY.
Tissue: Lung carcinoma.
[20]"Connexin 43 (GJA1) mutations cause the pleiotropic phenotype of oculodentodigital dysplasia."
Paznekas W.A., Boyadjiev S.A., Shapiro R.E., Daniels O., Wollnik B., Keegan C.E., Innis J.W., Dinulos M.B., Christian C., Hannibal M.C., Jabs E.W.
Am. J. Hum. Genet. 72:408-418(2003) [PubMed: 12457340] [Abstract]
Cited for: NON-ASSOCIATION WITH NON-SYNDROMIC AUTOSOMAL RECESSIVE DEAFNESS, VARIANTS ODDD SER-17; PRO-18; ARG-21; GLU-22; THR-23; VAL-40; LYS-49; PHE-52 INS; SER-76; VAL-90; CYS-98; ASN-102; THR-130; GLU-134; ARG-138; HIS-202 AND LEU-216, VARIANT VAL-253.
[21]"Mutations of the connexin43 gap-junction gene in patients with heart malformations and defects of laterality."
Britz-Cunningham S.H., Shah M.M., Zuppan C.W., Fletcher W.H.
N. Engl. J. Med. 332:1323-1329(1995) [PubMed: 7715640] [Abstract]
Cited for: VARIANTS HEART MALFORMATIONS GLY-352; PRO-364 AND ASN-365, VARIANTS ALA-326 AND GLY-373, CHARACTERIZATION OF VARIANT HEART MALFORMATIONS PRO-364.
[22]"Identification of connexin43 (alpha1) gap junction gene mutations in patients with hypoplastic left heart syndrome by denaturing gradient gel electrophoresis (DGGE)."
Dasgupta C., Martinez A.-M., Zuppan C.W., Shah M.M., Bailey L.L., Fletcher W.H.
Mutat. Res. 479:173-186(2001) [PubMed: 11470490] [Abstract]
Cited for: VARIANTS HLHS GLN-362 AND GLN-376, VARIANTS AVSD3 GLN-362 AND GLN-376, CHARACTERIZATION OF VARIANTS HLHS GLN-362 AND GLN-376.
[23]"Novel Connexin 43 (GJA1) mutation causes oculo-dento-digital dysplasia with curly hair."
Kjaer K.W., Hansen L., Eiberg H., Leicht P., Opitz J.M., Tommerup N.
Am. J. Med. Genet. A 127:152-157(2004) [PubMed: 15108203] [Abstract]
Cited for: VARIANT ODDD MET-96.
[24]"A homozygous GJA1 gene mutation causes a Hallermann-Streiff/ODDD spectrum phenotype."
Pizzuti A., Flex E., Mingarelli R., Salpietro C., Zelante L., Dallapiccola B.
Hum. Mutat. 23:286-286(2004) [PubMed: 14974090] [Abstract]
Cited for: VARIANT HSS HIS-76.
[25]"Expression of Gja1 correlates with the phenotype observed in oculodentodigital syndrome/type III syndactyly."
Richardson R.R., Donnai D., Meire F., Dixon M.J.
J. Med. Genet. 41:60-67(2004) [PubMed: 14729836] [Abstract]
Cited for: VARIANTS ODDD PRO-27; MET-31; VAL-40; TYR-69; PRO-113; ASN-134; GLN-148 AND HIS-202, VARIANT SDTY3 SER-143.
[26]"A novel GJA1 mutation causes oculodentodigital dysplasia without syndactyly."
Vitiello C., D'Adamo P., Gentile F., Vingolo E.M., Gasparini P., Banfi S.
Am. J. Med. Genet. A 133:58-60(2005) [PubMed: 15637728] [Abstract]
Cited for: VARIANT ODDD PRO-194.
[27]"Letter to the editor: Novel GJA1 mutation in oculodentodigital dysplasia."
Honkaniemi J., Kalkkila J.P., Koivisto P., Kahara V., Latvala T., Simola K.
Am. J. Med. Genet. A 139:48-49(2005) [PubMed: 16222672] [Abstract]
Cited for: VARIANT ODDD ARG-95.
[28]"A novel mutation in the GJA1 gene in a family with oculodentodigital dysplasia."
Vasconcellos J.P.C., Melo M.B., Schimiti R.B., Bressanim N.C., Costa F.F., Costa V.P.
Arch. Ophthalmol. 123:1422-1426(2005) [PubMed: 16219735] [Abstract]
Cited for: VARIANT ODDD HIS-59.
[29]"Mutations of connexin43 in fetuses with congenital heart malformations."
Chen P., Xie L.-J., Huang G.-Y., Zhao X.-Q., Chang C.
Chin. Med. J. 118:971-976(2005) [PubMed: 15978203] [Abstract]
Cited for: VARIANTS CONGENITAL HEART MALFORMATIONS TRP-239; THR-251; PRO-253; LEU-283 AND ASN-290.
[30]"Bigenic connexin mutations in a patient with hidrotic ectodermal dysplasia."
Kellermayer R., Keller M., Ratajczak P., Richardson E., Harangi F., Merei E., Melegh B., Kosztolanyi G., Richard G.
Eur. J. Dermatol. 15:75-79(2005) [PubMed: 15757815] [Abstract]
Cited for: VARIANT ECTODERMAL AND OCULODENTODIGITAL DYSPLASIA LEU-41.
[31]"Novel GJA1 mutations in patients with oculo-dento-digital dysplasia (ODDD)."
Debeer P., Van Esch H., Huysmans C., Pijkels E., De Smet L., Van de Ven W., Devriendt K., Fryns J.-P.
Eur. J. Med. Genet. 48:377-387(2005) [PubMed: 16378922] [Abstract]
Cited for: VARIANTS ODDD VAL-40; ASP-110; THR-147 AND PHE-169 DEL.
[32]"Clinical and genetic variability of oculodentodigital dysplasia."
Wiest T., Herrmann O., Stoegbauer F., Grasshoff U., Enders H., Koch M.J., Grond-Ginsbach C., Schwaninger M.
Clin. Genet. 70:71-72(2006) [PubMed: 16813608] [Abstract]
Cited for: VARIANTS ODDD GLU-96; PRO-113; ASN-154 AND TYR-220.
[33]"A novel GJA 1 mutation in oculo-dento-digital dysplasia with curly hair and hyperkeratosis."
Kelly S.C., Ratajczak P., Keller M., Purcell S.M., Griffin T., Richard G.
Eur. J. Dermatol. 16:241-245(2006) [PubMed: 16709485] [Abstract]
Cited for: VARIANT ODDD PRO-11.
[34]"Oculodentodigital dysplasia with mandibular retrognathism and absence of syndactyly: a case report with a novel mutation in the connexin 43 gene."
van Es R.J.J., Wittebol-Post D., Beemer F.A.
Int. J. Oral Maxillofac. Surg. 36:858-860(2007) [PubMed: 17509830] [Abstract]
Cited for: VARIANT ODDD ALA-154.
[35]"A new GJA1 (connexin 43) mutation causing oculodentodigital dysplasia associated to uncommon features."
de la Parra D.R., Zenteno J.C.
Ophthalmic Genet. 28:198-202(2007) [PubMed: 18161618] [Abstract]
Cited for: VARIANT ODDD VAL-2.
[36]"GJA1 mutations, variants, and connexin 43 dysfunction as it relates to the oculodentodigital dysplasia phenotype."
Paznekas W.A., Karczeski B., Vermeer S., Lowry R.B., Delatycki M., Laurence F., Koivisto P.A., Van Maldergem L., Boyadjiev S.A., Bodurtha J.N., Jabs E.W.
Hum. Mutat. 30:724-733(2009) [PubMed: 19338053] [Abstract]
Cited for: VARIANTS ODDD VAL-7; VAL-40; PRO-49; GLN-49 INS; ALA-96; PRO-106; ALA-154; PHE-201 AND HIS-202.
+Additional computationally mapped references.

Web resources

Cross-references

Sequence databases

EMBL
GenBank
DDBJ
X52947 mRNA. Translation: CAA37122.1.
M65188 mRNA. Translation: AAA52131.1.
AF151980 Genomic DNA. Translation: AAD37802.2.
CR541660 mRNA. Translation: CAG46461.1.
AK312324 mRNA. Translation: BAG35246.1.
AL139098 Genomic DNA. Translation: CAI20002.1.
CH471051 Genomic DNA. Translation: EAW48178.1.
BC026329 mRNA. Translation: AAH26329.1.
IPIIPI00218487.
PIRA35853.
RefSeqNP_000156.1. NM_000165.3.
UniGeneHs.74471.

3D structure databases

ProteinModelPortalP17302.
SMRP17302. Positions 3-234, 255-382.
ModBaseSearch...

Protein-protein interaction databases

IntActP17302. 2 interactions.
MINTMINT-147603.
STRINGP17302.

PTM databases

PhosphoSiteP17302.

Polymorphism databases

DMDM117706.

Proteomic databases

PeptideAtlasP17302.
PRIDEP17302.

Protocols and materials databases

StructuralBiologyKnowledgebaseSearch...

Genome annotation databases

EnsemblENST00000282561; ENSP00000282561; ENSG00000152661.
GeneID2697.
KEGGhsa:2697.
UCSCuc003pyr.1. human.

Organism-specific databases

CTD2697.
GeneCardsGC06P121798.
H-InvDBHIX0006183.
HGNCHGNC:4274. GJA1.
HPACAB010753.
MIM121014. gene.
164200. phenotype.
186100. phenotype.
234100. phenotype.
241550. phenotype.
257850. phenotype.
600309. phenotype.
neXtProtNX_P17302.
Orphanet90636. Autosomal recessive nonsyndromic sensorineural deafness type DFNB.
2248. Hypoplastic left heart syndrome.
2710. Oculodentodigital dysplasia.
93404. Syndactyly type 3.
PharmGKBPA28685.
GenAtlasSearch...

Phylogenomic databases

eggNOGprNOG06210.
HOGENOMHBG717760.
HOVERGENHBG009576.
InParanoidP17302.
OMATDGANVD.
OrthoDBEOG402WSC.
PhylomeDBP17302.

Enzyme and pathway databases

ReactomeREACT_11123. Membrane Trafficking.

Gene expression databases

ArrayExpressP17302.
BgeeP17302.
CleanExHS_GJA1.
GenevestigatorP17302.
GermOnlineENSG00000152661. Homo sapiens.

Family and domain databases

InterProIPR000500. Connexin.
IPR002261. Connexin43.
IPR013124. Connexin43_C.
IPR019570. Connexin_CCC.
IPR017990. Connexin_CS.
IPR013092. Connexin_N.
[Graphical view]
KOK07372.
PANTHERPTHR11984. Connexin. 1 hit.
PfamPF00029. Connexin. 1 hit.
PF03508. Connexin43. 1 hit.
PF10582. Connexin_CCC. 1 hit.
[Graphical view]
PRINTSPR00206. CONNEXIN.
PR01132. CONNEXINA1.
SMARTSM00037. CNX. 1 hit.
SM01089. Connexin_CCC. 1 hit.
[Graphical view]
PROSITEPS00407. CONNEXINS_1. 1 hit.
PS00408. CONNEXINS_2. 1 hit.
[Graphical view]
ProtoNetSearch...

Other

DrugBankDB01136. Carvedilol.
NextBio10668.
SOURCESearch...

Entry information

Entry nameCXA1_HUMAN
AccessionPrimary (citable) accession number: P17302
Secondary accession number(s): B2R5U9, Q6FHU1, Q9Y5I8
Entry history
Integrated into UniProtKB/Swiss-Prot: August 1, 1990
Last sequence update: January 23, 2007
Last modified: January 25, 2012
This is version 153 of the entry and version 2 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation programChordata Protein Annotation Program
DisclaimerAny medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.

Relevant documents

Human chromosome 6

Human chromosome 6: entries, gene names and cross-references to MIM

Human entries with polymorphisms or disease mutations

List of human entries with polymorphisms or disease mutations

Human polymorphisms and disease mutations

Index of human polymorphisms and disease mutations

MIM cross-references

Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot

SIMILARITY comments

Index of protein domains and families